The Venari Podcast

Shruti George on launching an industry first accelerator programme for Avery Dennison – AD Stretch

‘Sometimes you need people to just jump into things and say, “Look, it’s going to be uncertain, but we want to keep an open mind and then we’re going to figure it out together.”’
Shruti George, VP of Strategic Innovation Platforms at Avery Dennison, wanted to do more to develop and innovate new projects internally. With her brainchild, the AD Stretch Accelerator, the company can partner with international startups on a range of new sustainable packaging ventures.
Tim Hartnell, Senior Consultant for our Sustainable Packaging practice, welcomed Shruti to the Venari Podcast recently, where they discussed the Accelerator’s inception, the startup cohorts they’ve partnered with, and how to build and lead teams that drive innovation.
Check out the full interview here!

Insights From Ari Tulla - Nutrition As A Preventative Medicine | HealthTech CEO Series

‘We have to change the way we feed people and how we eat.’
 
Ari Tulla is on a mission to reframe food as medicine – and as CEO and founder of Elo Health, he’s doing all he can to implement his vision.
 
Longstanding family health issues first sparked Ari’s desire to make a positive difference by harnessing the power of healthy diets and nutrition. In this episode of the Venari Podcast’s HealthTech CEO series, our Digital Health consultant, Cristian Owen, spoke to Ari about the experiences that informed Elo’s launch, the company’s innovative approach to AI, and the changes Ari wants to see in how we approach health and nutrition.
 
Check out the full interview here!

BioTech Commercialisation & Working Within Pharma Partnerships | Eric Matthews | CCO Series

Best Hiring Practice For Fast-Growth BioTech, with Dr. Chris Winrow | R&D Hiring Strategy Series

‘I think an appreciation for translational research has really started to emerge over the past few years.’
Dr Chris Winrow has had an excellent vantage point from which to observe how approaches to translational research have changed in recent years. An expert in neurodegenerative disease, with over 20 years’ experience in pharma and biotech in a variety of research, translational, and clinical roles, he joined Lucy Therapeutics as CSO in March 2023.
Paula Doust Alba, our CNS & Rare Disease Consultant, welcomed Chris to an episode of the Venari Podcast’s R&D Hiring Strategy series to discuss his career, his thoughts on team building, what he looks for in new hires, and the future of translational research.
Check out the full interview!

Executing Effective Commercialisation Strategies: E.U. Vs U.S. | Chief Commercialisation Officer Series | The Venari Podcast

With over 30 years’ experience in launching and leading multi-billion-dollar blockbuster drug launches, Kirsten Detrick is more than qualified to discuss what is needed for successful commercial strategies in biopharma. She was most recently CCO at Endpoint Health, and remains sought-after by biotechs preparing for commercialisation.Kirsten spoke to our Life Sciences Commercial Consultant, Joe Knight, for the Venari Podcast Chief Commercial Officer series. Listen to their conversation which touched on Kirsten’s journey towards becoming a CCO, commercialisation and talent strategies!

From U.S. Military to HealthTech Founder: The Journey of Andrew Herr | HealthTech CEO Series

Launching in Rare Disease & Using Big Pharma Experience in a Biotech Setting | With Johanna Rossell

‘You can’t afford to drag with suboptimal performance.’Johanna Rossell, SVP General Manager Rare Diseases at Sumitomo Pharma America, has a wide range of professional experience to draw on when it comes to commercial biopharma. Her career has taken in stints in marketing and commercial across South America, Switzerland, and the US for a number of large companies prior to her recent experience as CCO of Enzyvant. Joe Knight, our Life Sciences Commercial Consultant, welcomed Johanna to the Venari Podcast for another episode of the Chief Commercial Officer series, where she opened up on what she’s learned from launches, when to bring in commercial teams, and her leadership philosophy of the ‘coach manager: the coach that can lead the multi-functional team’ while thinking long-term. 

Experiences of a First Time Founder - A Female Perspective | With Tatiana Fofanova | HealthTech CEO Series

Dr. Tatiana Fofanova’s journey towards establishing Koda Health took off in earnest during COVID. She was inspired to provide a patient-facing web application for users without access to certain treatments and medical documents.
Despite the necessity of such offerings, however, startup life has been a rollercoaster ride – particularly as female-founded companies rarely get the same levels of investment as male-founded ones...
Tatiana spoke to Cristian Owen, our Specialist Digital Health Consultant, for the Venari Podcast’s Healthtech CEOs series. Check out the episode to learn more about Koda’s work, the unequal playing field for startup funding, and Tatiana’s leadership insights.

Innovation - The Digital Twin at YVR | Director of Innovation & Technology, Chris Gilliland

 ‘Introducing new technologies – that’s always a challenge.’Aviation has returned to profitability, making it all the more important to keep pushing for new inventions and developments. Chris Gilliland knows all about this given his role as Director of Innovation and Technology at Vancouver International Airport - YVR.Our Senior Digital & Tech Consultant, Liv Britz, spoke to Chris on all things innovation in the airport space – in particular, YVR’s virtual replica, or digital twin – on the Venari Podcast. 

Mobilising A Team To Succeed & Long-term Commercial Strategies | With Greg Gangemi | CCO Series

‘Launching a product is one of the most exciting things you can do.’Life sciences product launches can be thrilling – if challenging. They require meticulous planning, a strong value proposition, and effective market access strategies – and Greg Gangemi knows all about this.Joe Knight, our Life Sciences Commercial Consultant, was delighted to host Greg on an episode of the Venari Podcast’s Chief Commercial Officer series.